These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 12722377
1. [The results of screening program for cervical cancer in Lodz]. Gottwald L, Giernat L, Lech W, Wójcik-Krowiranda K, Akoel KM, Kowalczyk-Amico K, Estemberg D, Grzesiak M, Sosnowski D, Guzowski G, Baś E, Tyliński W, Bieńkiewicz A. Ginekol Pol; 2002 Nov; 73(11):934-8. PubMed ID: 12722377 [Abstract] [Full Text] [Related]
2. [Estimated results of prophylactic physical examinations detecting cervical cancer in Center of Oncology in Bydgoszcz in years 2001-2003]. Mierzwa T, Grabiec M, Walentowicz M. Ginekol Pol; 2005 Sep; 76(9):693-8. PubMed ID: 16417080 [Abstract] [Full Text] [Related]
3. [Prophylactic medical investigations for breast cancer and uterine cervix cancer in Regional Oncology Centre of Bydgoszcz in 2003]. Mierzwa T, Grabiec M. Wiad Lek; 2004 Sep; 57 Suppl 1():207-10. PubMed ID: 15884240 [Abstract] [Full Text] [Related]
4. [Prophylactic medical examinations for breast cancer and uterine cervix cancer in Regional Oncological Center of Bydgoszcz in year 2002]. Mierzwa T, Siwek P, Grabiec M. Ginekol Pol; 2003 Sep; 74(9):811-6. PubMed ID: 14674129 [Abstract] [Full Text] [Related]
5. [Cervical cancer screening in Poland and worldwide]. Spaczyński M, Nowak-Markwitz E, Kedzia W. Ginekol Pol; 2007 May; 78(5):354-60. PubMed ID: 17867325 [Abstract] [Full Text] [Related]
6. [Comparative analysis of abnormal Pap smear and the results of histopathological examination of specimens from the cervix of the programme in-depth diagnosis cervical cancer conducted at the of Operational Gynecology Department ICZMP in Lodz]. Kulig B, Łukaszek S, Brucka A, Kałuzyński A, Kamer-Bartosińska A, Szyłło K. Ginekol Pol; 2010 Nov; 81(11):828-33. PubMed ID: 21365898 [Abstract] [Full Text] [Related]
7. [Verification of doubtful PAP smear results of women included in the screening program in the Podlaskie province]. Błońska E, Knapp PA. Ginekol Pol; 2013 Aug; 84(8):691-5. PubMed ID: 24191502 [Abstract] [Full Text] [Related]
8. Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program. Thipsanthiah K, Kamsa-Ard S, Musika W, Teemuangsai W, Hawlader MDH. Asian Pac J Cancer Prev; 2023 Oct 01; 24(10):3429-3436. PubMed ID: 37898847 [Abstract] [Full Text] [Related]
9. Prevalence of abnormal Papanicolaou smears in female sex workers in Hong Kong. Leung KM, Yeoh GP, Cheung HN, Fong FY, Chan KW. Hong Kong Med J; 2013 Jun 01; 19(3):203-6. PubMed ID: 23650200 [Abstract] [Full Text] [Related]
10. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years. Luyten A, Scherbring S, Reinecke-Lüthge A, Braun BE, Pietralla M, Theiler K, Petry KU. J Clin Virol; 2009 Nov 01; 46 Suppl 3():S5-10. PubMed ID: 20129072 [Abstract] [Full Text] [Related]
12. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia. Liao SY, Stanbridge EJ. Cancer; 2000 Mar 01; 88(5):1108-21. PubMed ID: 10699902 [Abstract] [Full Text] [Related]
13. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology. Bansal M, Zhao C. J Low Genit Tract Dis; 2011 Apr 01; 15(2):105-9. PubMed ID: 21317806 [Abstract] [Full Text] [Related]
14. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital. Lertcharernrit J, Sananpanichkul P, Suknikhom W, Bhamarapravatana K, Suwannarurk K, Leaungsomnapa Y. Asian Pac J Cancer Prev; 2016 Apr 01; 17(8):4163-7. PubMed ID: 27644678 [Abstract] [Full Text] [Related]
15. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data. Tiews S, Steinberg W, Schneider W, Hanrath C. J Clin Virol; 2009 Nov 01; 46 Suppl 3():S11-5. PubMed ID: 20129068 [Abstract] [Full Text] [Related]
16. Accuracy of the Papanicolaou test in the detection of high-grade cervical lesions. Repše-Fokter A. Int J Gynaecol Obstet; 2011 Jan 01; 112(1):65-6. PubMed ID: 21056413 [No Abstract] [Full Text] [Related]
17. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study. Strander B, Andersson-Ellström A, Milsom I, Rådberg T, Ryd W. Cancer; 2007 Oct 25; 111(5):285-91. PubMed ID: 17724676 [Abstract] [Full Text] [Related]
18. Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: implications for resource limited settings. Gupta S, Sodhani P, Halder K, Chachra KL, Sardana S, Singh V, Sehgal A. Eur J Obstet Gynecol Reprod Biol; 2007 Oct 25; 134(2):238-42. PubMed ID: 16920248 [Abstract] [Full Text] [Related]
19. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study. Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J, Morelos HPV Study Collaborators. Salud Publica Mex; 2002 Oct 25; 44(4):335-44. PubMed ID: 12216521 [Abstract] [Full Text] [Related]
20. [Cervical cancer screening by Pap smear: experience of the National Research Center in Reproductive Health. ONFP]. Ben Aissa R, Bennour R, Ben Hamida A, Kammoun N, Mansour H, Mhamdi A, Landoulsi S, Cherif N, Gueddana N. Tunis Med; 2002 Apr 25; 80(4):203-6. PubMed ID: 12416356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]